This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gaudreau, C. Articles by Gilbert, H. Search for Related Content PubMed PubMed Citation Articles by Gaudreau, C. Articles by Gilbert, H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2003, p. 2027-2029, Vol. 47, No. 6
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.6.2027-2029.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Antimicrobial Resistance of Campylobacter jejuni subsp. jejuni Strains Isolated from Humans in 1998 to 2001 in Montréal, Canada

Département de Microbiologie Médicale et Infectiologie, Hôpital Saint-Luc, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada H2X 3J4

Received 30 August 2002/ Returned for modification 29 December 2002/ Accepted 25 February 2003

The rates of resistance of 51 to 72 human strains of Campylobacter jejuni subsp. jejuni isolated annually from 1998 to 2001 in Montréal, Québec, Canada, varied from 1 to 12% for erythromycin, 43 to 68% for tetracycline, and 10 to 47% for ciprofloxacin. In the last years of the study, there was a significant increase in the rate of resistance to ciprofloxacin (P = 0.00003) but not in the rate of resistance to erythromycin (P = 0.056) or tetracycline (P = 0.095) compared to the rate obtained in the first years. All 51 C. jejuni strains isolated in 2001 were susceptible to gentamicin, amoxicillin-clavulanic acid, imipenem, and meropenem. From 1999 to 2001, 74 strains of C. jejuni acquired abroad were significantly more resistant to ciprofloxacin than 109 strains of C. jejuni acquired locally (66 versus 9%, P < 0.00001) but were not significantly more resistant to erythromycin (1 versus 6%, P = 0.15) or to tetracycline (55 versus 58%, P = 0.87).

This article has been cited by other articles:

• Gaudreau, C., Girouard, Y., Gilbert, H., Gagnon, J., Bekal, S. (2008). Comparison of Disk Diffusion and Agar Dilution Methods for Erythromycin, Ciprofloxacin, and Tetracycline Susceptibility Testing of Campylobacter coli and for Tetracycline Susceptibility Testing of Campylobacter jejuni subsp. jejuni. Antimicrob. Agents Chemother. 52: 4475-4477 [Abstract] [Full Text]  
• Quinn, T., Bolla, J.-M., Pages, J.-M., Fanning, S. (2007). Antibiotic-resistant Campylobacter: could efflux pump inhibitors control infection?. J Antimicrob Chemother 59: 1230-1236 [Abstract] [Full Text]  
• Gaudreau, C., Girouard, Y., Ringuette, L., Tsimiklis, C. (2007). Comparison of Disk Diffusion and Agar Dilution Methods for Erythromycin and Ciprofloxacin Susceptibility Testing of Campylobacter jejuni subsp. jejuni. Antimicrob. Agents Chemother. 51: 1524-1526 [Abstract] [Full Text]  
• Gibreel, A., Taylor, D. E. (2006). Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 58: 243-255 [Abstract] [Full Text]  
• Inglis, G. D., Morck, D. W., McAllister, T. A., Entz, T., Olson, M. E., Yanke, L. J., Read, R. R. (2006). Temporal Prevalence of Antimicrobial Resistance in Campylobacter spp. from Beef Cattle in Alberta Feedlots.. Appl. Environ. Microbiol. 72: 4088-4095 [Abstract] [Full Text]  
• Pratt, A., Korolik, V. (2005). Tetracycline resistance of Australian Campylobacter jejuni and Campylobacter coli isolates. J Antimicrob Chemother 55: 452-460 [Abstract] [Full Text]  
• Gibreel, A., Tracz, D. M., Nonaka, L., Ngo, T. M., Connell, S. R., Taylor, D. E. (2004). Incidence of Antibiotic Resistance in Campylobacter jejuni Isolated in Alberta, Canada, from 1999 to 2002, with Special Reference to tet(O)-Mediated Tetracycline Resistance. Antimicrob. Agents Chemother. 48: 3442-3450 [Abstract] [Full Text]